Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer

Apoptosis is important for targeting cancer cells for destruction. Various single-nucleotide polymorphisms (SNPs) in apoptotic genes have been associated with increased risks in lung cancer, particularly FAS −1377 G>A (rs2234767), FASLG −844 C>T (rs763110), IL1B +3954 C>T Phe105Phe (rs11436...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Carcinogenesis (New York) 2008-11, Vol.29 (11), p.2147-2152
Hauptverfasser: Ter-Minassian, Monica, Zhai, Rihong, Asomaning, Kofi, Su, Li, Zhou, Wei, Liu, Geoffrey, Heist, Rebecca Suk, Lynch, Thomas J., Wain, John C., Lin, Xihong, DeVivo, Immaculata, Christiani, David C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2152
container_issue 11
container_start_page 2147
container_title Carcinogenesis (New York)
container_volume 29
creator Ter-Minassian, Monica
Zhai, Rihong
Asomaning, Kofi
Su, Li
Zhou, Wei
Liu, Geoffrey
Heist, Rebecca Suk
Lynch, Thomas J.
Wain, John C.
Lin, Xihong
DeVivo, Immaculata
Christiani, David C.
description Apoptosis is important for targeting cancer cells for destruction. Various single-nucleotide polymorphisms (SNPs) in apoptotic genes have been associated with increased risks in lung cancer, particularly FAS −1377 G>A (rs2234767), FASLG −844 C>T (rs763110), IL1B +3954 C>T Phe105Phe (rs1143634) and BAT3 Ser625Pro (rs1052486). We studied the association of these SNPs with non-small cell lung cancer (NSCLC) in a large case–control study (N = 4263: 2644 cases and 1619 controls). No associations with NSCLC were observed in the main effects analysis for all four SNPs, adjusting for age, gender, smoking status, pack-years and years since smoking cessation. In subjects under age 60, for FASLG −844 C>T polymorphism, CT compared with the CC genotype, was significantly associated with increased risk of NSCLC, adjusted odds ratio (aOR) = 1.58 (1.22, 2.05), P  = 0.0006 and TT aOR = 1.45 (1.01, 2.04), P = 0.04. In contrast, for those over age 60, the CT aOR = 0.91 (0.73, 1.13), P = 0.37 and TT aOR = 0.86 (0.64, 1.16), P = 0.32. The P-value for the age–genotype interaction was 0.004. For the IL1B +3954 C>T polymorphism, compared with the CC genotype, TT showed significant associations in former smokers and in men but tests of interaction were not significant (Psmoking = 0.24, Pgender = 0.17). No interactions were observed for FAS −1377 G>A and BAT3 Ser625Pro polymorphisms. Our findings indicate that age and smoking may modify the association of the FASLG −844 and IL1B  + 3954 SNPs with the risk of NSCLC.
doi_str_mv 10.1093/carcin/bgn205
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2577138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/carcin/bgn205</oup_id><sourcerecordid>1590072841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c610t-4da979a4a1d41ee18fa1e8a836de22fd5feee369b16c8b6c2b2f1fa56df7d2213</originalsourceid><addsrcrecordid>eNqF0c-L1DAUB_AgijuuHr1KEBQPWzcvaZP2IiyD4wqLXlwQLyFNk0522qQmrbj_vR1axh8XL8khH77vvTyEngN5C6Ril1pF7fxl3XpKigdoAzknGYWSPEQbAjnLGGP5GXqS0h0hwFlRPUZnUIpCFFRs0O3VEIYxJJdwa7zBQ-ju-xCHvUt9usCqNRc49eHgfIuVb_C4Nzi6dMDBYh98lnrVdVib-eim2WjltYlP0SOrumSerfc5ut29_7K9zm4-f_i4vbrJNAcyZnmjKlGpXEGTgzFQWgWmVCXjjaHUNoU1xjBe1cB1WXNNa2rBqoI3VjSUAjtH75bcYap702jjx6g6OUTXq3gvg3Ly7xfv9rINPyQthABWzgGv14AYvk8mjbJ36TiN8iZMSUKVQ8VLMsOX_8C7MEU_DycpVCxnlBzTsgXpGFKKxp46ASKP25LLtuSyrdm_-LP933pdzwxerUAlrTob59916eSONYng-ezeLC5Mw39rrj26NJqfJ6ziQXLBRCGvv36Tu3JXwZZ8kgX7BRozvYU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219343208</pqid></control><display><type>article</type><title>Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ter-Minassian, Monica ; Zhai, Rihong ; Asomaning, Kofi ; Su, Li ; Zhou, Wei ; Liu, Geoffrey ; Heist, Rebecca Suk ; Lynch, Thomas J. ; Wain, John C. ; Lin, Xihong ; DeVivo, Immaculata ; Christiani, David C.</creator><creatorcontrib>Ter-Minassian, Monica ; Zhai, Rihong ; Asomaning, Kofi ; Su, Li ; Zhou, Wei ; Liu, Geoffrey ; Heist, Rebecca Suk ; Lynch, Thomas J. ; Wain, John C. ; Lin, Xihong ; DeVivo, Immaculata ; Christiani, David C.</creatorcontrib><description>Apoptosis is important for targeting cancer cells for destruction. Various single-nucleotide polymorphisms (SNPs) in apoptotic genes have been associated with increased risks in lung cancer, particularly FAS −1377 G&gt;A (rs2234767), FASLG −844 C&gt;T (rs763110), IL1B +3954 C&gt;T Phe105Phe (rs1143634) and BAT3 Ser625Pro (rs1052486). We studied the association of these SNPs with non-small cell lung cancer (NSCLC) in a large case–control study (N = 4263: 2644 cases and 1619 controls). No associations with NSCLC were observed in the main effects analysis for all four SNPs, adjusting for age, gender, smoking status, pack-years and years since smoking cessation. In subjects under age 60, for FASLG −844 C&gt;T polymorphism, CT compared with the CC genotype, was significantly associated with increased risk of NSCLC, adjusted odds ratio (aOR) = 1.58 (1.22, 2.05), P  = 0.0006 and TT aOR = 1.45 (1.01, 2.04), P = 0.04. In contrast, for those over age 60, the CT aOR = 0.91 (0.73, 1.13), P = 0.37 and TT aOR = 0.86 (0.64, 1.16), P = 0.32. The P-value for the age–genotype interaction was 0.004. For the IL1B +3954 C&gt;T polymorphism, compared with the CC genotype, TT showed significant associations in former smokers and in men but tests of interaction were not significant (Psmoking = 0.24, Pgender = 0.17). No interactions were observed for FAS −1377 G&gt;A and BAT3 Ser625Pro polymorphisms. Our findings indicate that age and smoking may modify the association of the FASLG −844 and IL1B  + 3954 SNPs with the risk of NSCLC.</description><identifier>ISSN: 0143-3334</identifier><identifier>EISSN: 1460-2180</identifier><identifier>DOI: 10.1093/carcin/bgn205</identifier><identifier>PMID: 18757527</identifier><identifier>CODEN: CRNGDP</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Age Factors ; Aged ; Aged, 80 and over ; Apoptosis - genetics ; Biological and medical sciences ; Carcinogenesis, carcinogens and anticarcinogens ; Carcinoma, Non-Small-Cell Lung - genetics ; Case-Control Studies ; Fas Ligand Protein - genetics ; fas Receptor - genetics ; Humans ; Interleukin-1beta - genetics ; Lung cancer ; Lung Neoplasms - genetics ; Medical sciences ; Middle Aged ; Molecular Epidemiology ; Pneumology ; Polymorphism, Single Nucleotide ; Smoking ; Tobacco, tobacco smoking ; Toxicology ; Tumors ; Tumors of the respiratory system and mediastinum</subject><ispartof>Carcinogenesis (New York), 2008-11, Vol.29 (11), p.2147-2152</ispartof><rights>Published by Oxford University Press 2008. 2008</rights><rights>2009 INIST-CNRS</rights><rights>Published by Oxford University Press 2008.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c610t-4da979a4a1d41ee18fa1e8a836de22fd5feee369b16c8b6c2b2f1fa56df7d2213</citedby><cites>FETCH-LOGICAL-c610t-4da979a4a1d41ee18fa1e8a836de22fd5feee369b16c8b6c2b2f1fa56df7d2213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20830764$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18757527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ter-Minassian, Monica</creatorcontrib><creatorcontrib>Zhai, Rihong</creatorcontrib><creatorcontrib>Asomaning, Kofi</creatorcontrib><creatorcontrib>Su, Li</creatorcontrib><creatorcontrib>Zhou, Wei</creatorcontrib><creatorcontrib>Liu, Geoffrey</creatorcontrib><creatorcontrib>Heist, Rebecca Suk</creatorcontrib><creatorcontrib>Lynch, Thomas J.</creatorcontrib><creatorcontrib>Wain, John C.</creatorcontrib><creatorcontrib>Lin, Xihong</creatorcontrib><creatorcontrib>DeVivo, Immaculata</creatorcontrib><creatorcontrib>Christiani, David C.</creatorcontrib><title>Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer</title><title>Carcinogenesis (New York)</title><addtitle>Carcinogenesis</addtitle><description>Apoptosis is important for targeting cancer cells for destruction. Various single-nucleotide polymorphisms (SNPs) in apoptotic genes have been associated with increased risks in lung cancer, particularly FAS −1377 G&gt;A (rs2234767), FASLG −844 C&gt;T (rs763110), IL1B +3954 C&gt;T Phe105Phe (rs1143634) and BAT3 Ser625Pro (rs1052486). We studied the association of these SNPs with non-small cell lung cancer (NSCLC) in a large case–control study (N = 4263: 2644 cases and 1619 controls). No associations with NSCLC were observed in the main effects analysis for all four SNPs, adjusting for age, gender, smoking status, pack-years and years since smoking cessation. In subjects under age 60, for FASLG −844 C&gt;T polymorphism, CT compared with the CC genotype, was significantly associated with increased risk of NSCLC, adjusted odds ratio (aOR) = 1.58 (1.22, 2.05), P  = 0.0006 and TT aOR = 1.45 (1.01, 2.04), P = 0.04. In contrast, for those over age 60, the CT aOR = 0.91 (0.73, 1.13), P = 0.37 and TT aOR = 0.86 (0.64, 1.16), P = 0.32. The P-value for the age–genotype interaction was 0.004. For the IL1B +3954 C&gt;T polymorphism, compared with the CC genotype, TT showed significant associations in former smokers and in men but tests of interaction were not significant (Psmoking = 0.24, Pgender = 0.17). No interactions were observed for FAS −1377 G&gt;A and BAT3 Ser625Pro polymorphisms. Our findings indicate that age and smoking may modify the association of the FASLG −844 and IL1B  + 3954 SNPs with the risk of NSCLC.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Apoptosis - genetics</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Case-Control Studies</subject><subject>Fas Ligand Protein - genetics</subject><subject>fas Receptor - genetics</subject><subject>Humans</subject><subject>Interleukin-1beta - genetics</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - genetics</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Molecular Epidemiology</subject><subject>Pneumology</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Smoking</subject><subject>Tobacco, tobacco smoking</subject><subject>Toxicology</subject><subject>Tumors</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0143-3334</issn><issn>1460-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c-L1DAUB_AgijuuHr1KEBQPWzcvaZP2IiyD4wqLXlwQLyFNk0522qQmrbj_vR1axh8XL8khH77vvTyEngN5C6Ril1pF7fxl3XpKigdoAzknGYWSPEQbAjnLGGP5GXqS0h0hwFlRPUZnUIpCFFRs0O3VEIYxJJdwa7zBQ-ju-xCHvUt9usCqNRc49eHgfIuVb_C4Nzi6dMDBYh98lnrVdVib-eim2WjltYlP0SOrumSerfc5ut29_7K9zm4-f_i4vbrJNAcyZnmjKlGpXEGTgzFQWgWmVCXjjaHUNoU1xjBe1cB1WXNNa2rBqoI3VjSUAjtH75bcYap702jjx6g6OUTXq3gvg3Ly7xfv9rINPyQthABWzgGv14AYvk8mjbJ36TiN8iZMSUKVQ8VLMsOX_8C7MEU_DycpVCxnlBzTsgXpGFKKxp46ASKP25LLtuSyrdm_-LP933pdzwxerUAlrTob59916eSONYng-ezeLC5Mw39rrj26NJqfJ6ziQXLBRCGvv36Tu3JXwZZ8kgX7BRozvYU</recordid><startdate>20081101</startdate><enddate>20081101</enddate><creator>Ter-Minassian, Monica</creator><creator>Zhai, Rihong</creator><creator>Asomaning, Kofi</creator><creator>Su, Li</creator><creator>Zhou, Wei</creator><creator>Liu, Geoffrey</creator><creator>Heist, Rebecca Suk</creator><creator>Lynch, Thomas J.</creator><creator>Wain, John C.</creator><creator>Lin, Xihong</creator><creator>DeVivo, Immaculata</creator><creator>Christiani, David C.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20081101</creationdate><title>Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer</title><author>Ter-Minassian, Monica ; Zhai, Rihong ; Asomaning, Kofi ; Su, Li ; Zhou, Wei ; Liu, Geoffrey ; Heist, Rebecca Suk ; Lynch, Thomas J. ; Wain, John C. ; Lin, Xihong ; DeVivo, Immaculata ; Christiani, David C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c610t-4da979a4a1d41ee18fa1e8a836de22fd5feee369b16c8b6c2b2f1fa56df7d2213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Apoptosis - genetics</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Case-Control Studies</topic><topic>Fas Ligand Protein - genetics</topic><topic>fas Receptor - genetics</topic><topic>Humans</topic><topic>Interleukin-1beta - genetics</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - genetics</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Molecular Epidemiology</topic><topic>Pneumology</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Smoking</topic><topic>Tobacco, tobacco smoking</topic><topic>Toxicology</topic><topic>Tumors</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ter-Minassian, Monica</creatorcontrib><creatorcontrib>Zhai, Rihong</creatorcontrib><creatorcontrib>Asomaning, Kofi</creatorcontrib><creatorcontrib>Su, Li</creatorcontrib><creatorcontrib>Zhou, Wei</creatorcontrib><creatorcontrib>Liu, Geoffrey</creatorcontrib><creatorcontrib>Heist, Rebecca Suk</creatorcontrib><creatorcontrib>Lynch, Thomas J.</creatorcontrib><creatorcontrib>Wain, John C.</creatorcontrib><creatorcontrib>Lin, Xihong</creatorcontrib><creatorcontrib>DeVivo, Immaculata</creatorcontrib><creatorcontrib>Christiani, David C.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Carcinogenesis (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ter-Minassian, Monica</au><au>Zhai, Rihong</au><au>Asomaning, Kofi</au><au>Su, Li</au><au>Zhou, Wei</au><au>Liu, Geoffrey</au><au>Heist, Rebecca Suk</au><au>Lynch, Thomas J.</au><au>Wain, John C.</au><au>Lin, Xihong</au><au>DeVivo, Immaculata</au><au>Christiani, David C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer</atitle><jtitle>Carcinogenesis (New York)</jtitle><addtitle>Carcinogenesis</addtitle><date>2008-11-01</date><risdate>2008</risdate><volume>29</volume><issue>11</issue><spage>2147</spage><epage>2152</epage><pages>2147-2152</pages><issn>0143-3334</issn><eissn>1460-2180</eissn><coden>CRNGDP</coden><abstract>Apoptosis is important for targeting cancer cells for destruction. Various single-nucleotide polymorphisms (SNPs) in apoptotic genes have been associated with increased risks in lung cancer, particularly FAS −1377 G&gt;A (rs2234767), FASLG −844 C&gt;T (rs763110), IL1B +3954 C&gt;T Phe105Phe (rs1143634) and BAT3 Ser625Pro (rs1052486). We studied the association of these SNPs with non-small cell lung cancer (NSCLC) in a large case–control study (N = 4263: 2644 cases and 1619 controls). No associations with NSCLC were observed in the main effects analysis for all four SNPs, adjusting for age, gender, smoking status, pack-years and years since smoking cessation. In subjects under age 60, for FASLG −844 C&gt;T polymorphism, CT compared with the CC genotype, was significantly associated with increased risk of NSCLC, adjusted odds ratio (aOR) = 1.58 (1.22, 2.05), P  = 0.0006 and TT aOR = 1.45 (1.01, 2.04), P = 0.04. In contrast, for those over age 60, the CT aOR = 0.91 (0.73, 1.13), P = 0.37 and TT aOR = 0.86 (0.64, 1.16), P = 0.32. The P-value for the age–genotype interaction was 0.004. For the IL1B +3954 C&gt;T polymorphism, compared with the CC genotype, TT showed significant associations in former smokers and in men but tests of interaction were not significant (Psmoking = 0.24, Pgender = 0.17). No interactions were observed for FAS −1377 G&gt;A and BAT3 Ser625Pro polymorphisms. Our findings indicate that age and smoking may modify the association of the FASLG −844 and IL1B  + 3954 SNPs with the risk of NSCLC.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>18757527</pmid><doi>10.1093/carcin/bgn205</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0143-3334
ispartof Carcinogenesis (New York), 2008-11, Vol.29 (11), p.2147-2152
issn 0143-3334
1460-2180
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2577138
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Age Factors
Aged
Aged, 80 and over
Apoptosis - genetics
Biological and medical sciences
Carcinogenesis, carcinogens and anticarcinogens
Carcinoma, Non-Small-Cell Lung - genetics
Case-Control Studies
Fas Ligand Protein - genetics
fas Receptor - genetics
Humans
Interleukin-1beta - genetics
Lung cancer
Lung Neoplasms - genetics
Medical sciences
Middle Aged
Molecular Epidemiology
Pneumology
Polymorphism, Single Nucleotide
Smoking
Tobacco, tobacco smoking
Toxicology
Tumors
Tumors of the respiratory system and mediastinum
title Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T05%3A32%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Apoptosis%20gene%20polymorphisms,%20age,%20smoking%20and%20the%20risk%20of%20non-small%20cell%20lung%20cancer&rft.jtitle=Carcinogenesis%20(New%20York)&rft.au=Ter-Minassian,%20Monica&rft.date=2008-11-01&rft.volume=29&rft.issue=11&rft.spage=2147&rft.epage=2152&rft.pages=2147-2152&rft.issn=0143-3334&rft.eissn=1460-2180&rft.coden=CRNGDP&rft_id=info:doi/10.1093/carcin/bgn205&rft_dat=%3Cproquest_pubme%3E1590072841%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219343208&rft_id=info:pmid/18757527&rft_oup_id=10.1093/carcin/bgn205&rfr_iscdi=true